CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 5 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05625802
NCT05625802Phase 2Completed
CompareCT.gov

Erector Spinae Plane Block for Uncomplicated Renal Colic

University of Michigan·interventional·Posted Nov 23, 2022·Updated Oct 30, 2025

In Brief

A Phase 2 clinical trial evaluating Erector Spinae Plane Block (ESPB) and Ropivacaine for Renal Colic and Kidney Stone. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This research study is to determine how well the Erector Spinae Plane Block (ESPB) works for kidney stone pain and any possible side effects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Colic, Kidney Stone
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2023202420252026
First PostedNov 23, 2022
Enrollment StartFeb 8, 2023
Primary CompletionJan 3, 2024
Study CompletionFeb 2, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.6 years ago

Interventions

Erector Spinae Plane Block (ESPB)procedure

Up to 30 Cubic Centimeter (cc) of 0.5% ropivacaine administered by local injection into the erector spinae plane under ultrasound guidance

Ropivacainedrug

0.5% ropivacaine